Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Relatlimab + Immunotherapy for Nasopharyngeal Cancer
Recruiting1 awardPhase 2
Newport Beach, California
This trial is testing a new drug called BMS-986016 (relatlimab) in combination with standard immunotherapy for patients with nasopharyngeal cancer. Nasopharyngeal
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.